Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-015846
Filing Date
2012-11-08
Accepted
2012-11-08 19:56:50
Documents
1
Period of Report
2012-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7055
  Complete submission text file 0001179110-12-015846.txt   8434
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Foster-Cheek Kaye I (Reporting) CIK: 0001312622 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28298 | Film No.: 121191416